Regeneron Pharmaceuticals ESMO 2024 Investor Event

Loading viewer...

investor_presentation

Format: PDF investor_presentation

Regeneron Pharmaceuticals presented investigational data and forward-looking statements at the European Society for Medical Oncology 2024 Investor Event on September 16, 2024. The presentation covered multiple oncology and hematology product candidates and programs, including EYLEA HD, Dupixent, Libtayo, and costimulatory bispecific portfolio initiatives.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Regeneron Pharmaceuticals, Inc.

View all →

Regeneron Pharmaceuticals 2016 Bank of America Healthcare Conference

conference

23 Pages

Regeneron Pharmaceuticals 2022 Corporate Investor Presentation

investor_presentation

Similar investor_presentations from other companies

Browse all →

C3.ai Investor Presentation — March 2022

investor_presentation

20 Pages

C3 AI

ISG Investor Presentation April 2022

investor_presentation